Dysfunction of the prefrontal cortex may contribute to the autistic features and mental retardation of Rett syndrome, a neuropsychiatric condition caused by mutations of the gene encoding methyl-CpGbinding protein 2 (MeCP2). Because nothing is known about the expression of MeCP2 and other chromatin-associated factors in primate brain, we studied in monkey prefrontal cortex and murine cerebral cortex expression patterns of MeCP2 and of macrohistone H2A (MacroH2A), which like MeCP2 is associated with transcriptionally silent chromatin. In both species, MeCP2 and MacroH2A appeared to be ubiquitously expressed by cortical neurons, including projection neurons and GABAergic interneurons. In the adult monkey, MeCP2 expression was robust throughout all layers of the prefrontal cortex but it was limited in fetal monkeys at embryonic day 110 to the deeper cortical layers and the subplate. These results suggest that MeCP2 may be important for neuronal maintenance in the developing and in the mature primate prefrontal cortex, consistent with the previously reported phenotype of MeCP2-null mutant mice.
INTRODUCTION
Rett syndrome (RTT) is a disabling neuropsychiatric condition with onset in early childhood (Hagberg et al., 1985; Rett, 1992) . The disease is caused by deleterious mutations of the X-linked gene encoding methylCpG-binding protein 2 (MECP2) (Amir et al., 1999) . MeCP2 binds to methylated cytosine residues in genomic DNA and is likely to mediate the biological role of DNA methylation, including transcriptional repression and chromatin condensation (Bird & Wolffe, 1999) . Loss of MeCP2 function ultimately leads to neuronal disease, and the neuropathology both of Rett patients and of MeCP2-null mutant mice is characterized by decreased brain weight, increased cell packing density, and neuronal dystrophy in the cerebral cortex and other brain regions (Armstrong, 1992; Baumann et al., 1995; Naidu, 1997; Chen et al., 2001) .
RTT has been considered to be a manifestation of defective brain development (for review see Naidu, 1997; Wenk, 1997) . However, Mecp2-null mutant mice do not show behavioral symptoms until brain development is complete suggesting that MeCP2 may remain essential for maintenance of neuronal health beyond the developmental period (Chen et al., 2001; Guy et al., 2001) . This important conclusion is based on experiments with genetically engineered mice and it is yet unclear whether the findings can be extrapolated to the primate, including human, brain.
MeCP2, as a chromatin-associated protein, is likely to act in a cell autonomous fashion (Bird & Wolffe, 
